Cell-mediated immunity to herpes simplex virus envelope, capsid, excreted, and crude antigens was studied by in vitro lymphocyte stimulation tests during 198 recurrent attacks in 69 patients. Excreted antigen caused no blast transformation. Envelope and capsid antigen-induced lymphocyte stimulation was at the maximum 7 to 14 days postinfection, declining thereafter to a rather constant level in 1 to 2 months. The lowest levels were measured just a few days before a new attack. In persons with frequent relapses, the fluctuation was more rapid and stimulation index levels stayed higher, although no protective level seemed to exist. Cultures stimulated with the crude antigen in autologous serum showed rapid increases and declines in the stimulation index values, contrary to those grown in agamma serum, in which the stimulation level stayed rather constant up to 1 year postinfection.
Herpes simplex virus (HSV) infections are an annoying medical problem. About 80 to 90% of the population gets the infection, and a recurrent infection occurs in 50 to 60% of these persons.
Different causes have been suggested for the recurrent attacks. Interest has been focused on both humoral and cell-mediated immune responses. A slightly elevated level of specific anti-HSV antibodies has been detected in persons who develop several recurrences compared with those who have no repeat infections (3) (4) (5) . In cell-mediated immunity, increased (2), decreased (8, 21) , and fluctuating values in blast transformation tests have been reported (8, 18) , suggesting that a possible defect lies in the cellmediated immune system. Differences in the mediators released from the lymphocytes have also been found (11, 15, 18, 20) .
When virus-specific antibodies are measured against different structural components of HSV, a time sequence is found in their appearance.
Antibodies against envelope antigen are detected first, followed by those against capsid and excreted antigens (5) . A similar time sequence in the response to different HSV antigens might exist in cell-mediated immunity as well. Animal models of HSV infections suggest that the envelope antigen is the major target for immunoresponsive lymphocytes and mediators released by lymphocytes (9, 13) . So far no human study exists in which cell-mediated immunity against these structural subunits has been measured during HSV infections. In this report we Kaplan et al. (7) . Corresponding control antigens were prepared from noninfected cells in a manner similar to that for viral antigens.
For blast transformation assays, the HSV antigens were inactivated by P-propionlactone treatment according to the method of Neff and Enders (12) . In lymphocyte transformation tests, different antigen concentrations were used, as follows: crude antigen, 30 and 6 ,g/ml; capsid antigen, 2, 0.4, and 0.08 Rg/ml; envelope antigen, 3, 0.6, and 0.12 ,ug/ml; and excreted antigen, 15, 3, and 0.6 ,ug/ml.
Blast transformation was also induced by phytohemagglutinin (375 and 75 ,ug/ml; Difco Laboratories, Detroit, Mich.) and purified protein derivative (4 and 0.04 Rg/ml; CVL, London, England).
Lymphocyte stimulation tests. Lymphocytes were isolated by a Ficoll-Hypaque gradient (Pharmacia, Uppsala, Sweden) according to the method described by Boyum (1) T-and B-cell determinations. T-cell determinations were made according to Wybran et al. (22) and B-cell determinations were made according to Pettersson et al. (17) .
Antibody determinations. A solid-phase radioimmunoassay used to detect class-specific HSV antibodies has been described in detail earlier (5, 6) . In this study, IgA, IgG, and IgM class antibodies against HSV envelope antigen were determined.
RESULTS
During the follow-up, 198 recurrent HSV infections were registered. One attack was seen in 16 patients; 2, in 19 patients; 3, in 4 patients; and 4 or more, in 15 patients. Fifteen persons were completely symptom-free during the period followed, although they had a history of several recurrent HSV infections before the follow-up started. However, blood samples were taken regularly, and thus these patients served as HSV-positive, nonrecurrent controls.
Both the relative number of leukocytes and the amount of T-and B-cells showed some variation. However, generally the proportions were within normal limits. The number of Tcells represented 50 to 75% of the lymphocyte population and that of B-cells represented 5 to 20%. The total leukocyte and B-or T-cell counts showed no evident connection with the recurrent infections or changes in SI levels to various HSV antigens in individual patients.
Cell-mediated immunity. HSV excreted antigen and the control antigens caused no blast transformation. The persons who had no history of previous HSV infections were also negative in lymphocyte stimulation studies with HSV antigens.
For the envelope, capsid, and crude antigens the SI values were at their lowest just before the onset of infection, staying at the low level 1 to 5 days after the viral vesicles had appeared. The mean SI values for all patients during recurrent attacks are presented in Fig. 1 for the different HSV antigens, when the strongest antigen concentrations were used for stimulation. Different curves are established for those patients who had frequent, rather frequent, and nonrelapsing attacks. The SI values started to increase in a few days and were highest 7 to 14 days after the beginning of the eruption. The level started to decline soon after the maximum was gained, and a definite decrease was seen by 30 days after the beginning of the eruption. In patients who had frequent recurrent infections the SI values started to decline more rapidly than in those who had only occasional relapses. Capsid antigen-induced blast transformation was exceptional since the mean SI value was rather constant; however, in individual patients the tendency to fluctuate was evident (Fig. 2) . When lower concentrations of viral antigens were used for stimulation, a similar fluctuation was noticed, although the SI values stayed at a lower level.
The blast transformation induced by the crude antigen was studied by incubating the cells with both agamma and patients' own autologous sera. When autologous serum was used the SI level started to decrease 30 days after the attack. In contrast, the blast transformation index with agamma serum stayed at a higher level up to 1 year after infection (Fig. 1D ). (Fig. 2) .
The HSV antigens used induced lymphocyte stimulation in each patient studied. Patients with HSV infection in the genital area or other locations did not differ from those with labial infections.
The no blast transformation, as expected since it is possibly not a structural viral antigen (5). Envelope, capsid, and crude antigens did induce a blast transformation, which reached the maximum 1 to 2 weeks after the eruption and was at the lowest just before the beginning of the next eruption. The increase and decrease in SI level induced by envelope antigen preceded that induced by capsid antigen. The SI levels evoked by the crude antigen were highest, as expected since it represents a combination of various HSV antigens. The structural antigens used were not type specific since no differences were seen in the patients with various clinical pictures. This is in accordance with previous findings (5) .
In patients who had frequent recurrences, the SI values induced by HSV antigens declined faster than in the others. This supports the idea of a possible immunological defect in these patients, noticed previously by Kirchner et al. (8) .
The effect of autologous serum in the incubation solution was compared with agamma serum in crude antigen-induced cultures. An evident difference was seen in that cultures stimulated with autologous serum showed decreasing stimulation values 14 days after eruption whereas the SI levels in agamma serum-treated cultures stayed at a high level up to 1 year after infection. It has been suggested that antibodies could bind to the specific antigens, and depending on the antigen-antibody ratios in the system, the antibodies may increase or impair the antigen-induced stimulation of lymphocytes (14) . On the other hand, antibody-mediated cytotoxicity may affect the circulating cell population, recognizing and killing HSV-sensitized cells (16) . However, the blast transformation indices in autologous serum fell rather rapidly after the acute phase of the infection, although the HSV antibody levels did not show fluctuations.
Although a constant fluctuation was seen in the structural HSV antigen-induced lymphocyte SI values, the clinical course of the attacks did not follow these parameters strictly. High SI levels did not prevent further attacks. It thus appears evident that immunotherapy, e.g., vaccination with HSV antigen, will not prevent future relapses. 
